Cargando…
Cancer stem cell targeted therapy: progress amid controversies
Although cancer stem cells have been well characterized in numerous malignancies, the fundamental characteristics of this group of cells, however, have been challenged by some recent observations: cancer stem cells may not necessary to be rare within tumors; cancer stem cells and non-cancer stem cel...
Autores principales: | Wang, Tao, Shigdar, Sarah, Gantier, Michael P., Hou, Yingchun, Wang, Li, Li, Yong, Shamaileh, Hadi Al, Yin, Wang, Zhou, Shu-Feng, Zhao, Xinhan, Duan, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792551/ https://www.ncbi.nlm.nih.gov/pubmed/26496035 |
Ejemplares similares
-
Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
por: AlShamaileh, Hadi, et al.
Publicado: (2017) -
Author Correction: Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
por: AlShamaileh, Hadi, et al.
Publicado: (2020) -
EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model
por: Wang, Tao, et al.
Publicado: (2015) -
Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
por: Xiang, Dongxi, et al.
Publicado: (2017) -
Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures
por: Rahimizadeh, Kamal, et al.
Publicado: (2017)